Todd Hornsby - 10 Jan 2024 Form 4 Insider Report for Apyx Medical Corp (APYX)

Reporting relationship: Executive Vice President
Issuer ticker: APYX
Reported as of: 10 Jan 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Jan 2024, 16:05:44 UTC
Prior SEC filing: 29 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Todd Hornsby

Key filing fact

Todd Hornsby filed Form 4 for Apyx Medical Corp (APYX) on 11 Jan 2024.

Key facts

This page summarizes Todd Hornsby's Form 4 filing for Apyx Medical Corp (APYX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 11 Jan 2024, 16:05.

Change

Previous filing in this sequence was filed on 29 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

APYX transaction Derivative

Stock Option (Option to Buy)

Award

Transaction value: $0
Shares: +100,000
Change %
Price: $0.000000^*
Shares after: 0
Date: 10 Jan 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $2.42
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.